Invasive pulmonary aspergillosis in a patient with cirrhosis

Heather L Clark1, Hugo E Valencia1, Jennifer J Findeis-Hosey2

  • 1Department of Medicine, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642 United States.

Idcases
|March 7, 2020
PubMed

Insights

Invasive aspergillosis, a serious fungal infection, is often missed in critically ill patients. Early consideration is vital due to high mortality rates in these vulnerable populations.

Area of Science:

  • Mycology
  • Critical Care Medicine
  • Infectious Diseases

Background:

  • Aspergillus molds are common environmental fungi capable of causing severe invasive infections.
  • Invasive fungal infections, particularly aspergillosis, are frequently underdiagnosed in critically ill patients.
  • These infections often lack typical clinical presentations in immunocompromised individuals.

Purpose of the Study:

  • To highlight a case of invasive pulmonary aspergillosis in a critically ill patient without classic risk factors.
  • To review the diagnostic challenges and management strategies for invasive fungal infections in critically ill populations.
  • To emphasize the importance of considering invasive fungal infections in undiagnosed sepsis cases.

Main Methods:

  • Case presentation of a 68-year-old female with multiple comorbidities presenting with sepsis-like symptoms.
  • Review of diagnostic workup, including imaging and laboratory tests, which were initially non-diagnostic for fungal infection.
  • Autopsy confirmation of invasive pulmonary aspergillosis.

Main Results:

  • The patient presented with non-specific symptoms and negative routine infectious workup, leading to delayed diagnosis.
  • Chest imaging revealed nodular densities and bilateral opacities, suggestive of pneumonia.
  • Autopsy confirmed invasive pulmonary aspergillosis, revealing the true cause of the patient's decline.

Conclusions:

  • Invasive fungal infections, such as aspergillosis, are often missed in critically ill patients, especially those without typical risk factors.
  • High mortality rates associated with invasive fungal infections necessitate increased clinical suspicion and prompt diagnosis.
  • Consideration of invasive fungal infections is crucial in the differential diagnosis of critically ill patients with unexplained sepsis or respiratory failure.

Related Concept Videos

Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
868
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
755
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
650
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
436
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.4K